Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: PrimeraDx Names New VP of Business Development

Premium

PrimeraDx said this week that David Jackson has been appointed as vice president of business development.

Jackson most recently was employed at Qiagen, where he served as a member of the companion diagnostics partnerships team as part of global business development. Prior to that, he held a similar VP role with DxS, which was acquired by Qiagen in 2009. Jackson also has experience in business and corporate development, strategic marketing, commercialization, and intellectual property analysis. He holds a PhD in medical sciences from the Boston University School of Medicine, and is trained as a US patent agent and securities analyst.

Filed under

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.